Syntekabio Company

Syntekabio is a public company, listed on the KOSDAQ. It is an AI drug discovery and development company based on genomic big data.

Last Funding Type: Post-IPO Equity
Funding Status: IPO
Headquarters: Daejeon, Taejon-jikhalsi, South Korea
Founded Date: 2009-09-15
Investor Type: Undisclosed
Investment Stage: N/A
Last Funding Date: 2019-12-17
Total Funding: 183902559.0
Technology: AI based drug discovery and patient stratification, Self-developed bioinformatics tools for analyzing genomic data
Employee Number: 30-50
Number Of Exists: 1
Investors Number: 7.0
Industry: Early Drug Development